Search Results - "Dahlof, Carl G.H."
-
1
Determining Triptan Preference for the Individual Patient
Published in Headache (01-07-2004)Get full text
Journal Article -
2
Randomized, controlled trial of telcagepant over four migraine attacks
Published in Cephalalgia (01-12-2010)“…This study evaluated the calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant (tablet formulation) for treatment of a migraine attack and…”
Get more information
Journal Article -
3
Prevalence and Diagnosis of Migraine in Patients Consulting Their Physician With a Complaint of Headache: Data From the Landmark Study
Published in Headache (01-10-2004)“…Context.—Headache experts have suggested that to improve the recognition of migraine, patients with a stable pattern of episodic, disabling headache and a…”
Get full text
Journal Article -
4
Applications of Computerized Adaptive Testing (CAT) to the Assessment of Headache Impact
Published in Quality of life research (01-12-2003)“…Objective: To evaluate the feasibility of computerized adaptive testing (CAT) and the reliability and validity of CAT-based estimates of headache impact scores…”
Get full text
Journal Article -
5
Rizatriptan in the treatment of migraine
Published in Clinical therapeutics (01-11-1999)“…Rizatriptan is a selective 5-hydroxytriptamine 1B/1D receptor agonist that was launched in 1998 for the acute treatment of migraine in adults. Based on data…”
Get full text
Journal Article -
6
Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets
Published in Clinical therapeutics (01-04-2005)“…The gastric stasis that commonly accompanieBackground:722 migraine headache may impair absorption of conventional oral tablets in the stomach. A…”
Get full text
Journal Article -
7
The burden of migraine to the individual sufferer: a review
Published in European journal of neurology (01-11-1998)“…This review of the literature reveals that migraine is a common, chronic condition featuring episodic attacks which vary in severity and symptomatology…”
Get full text
Journal Article -
8
How Does Almotriptan Compare With Other Triptans? A Review of Data From Placebo-Controlled Clinical Trials
Published in Headache (01-02-2002)“…Almotriptan, the new selective 5‐HT1B/1D agonist, has a higher oral bioavailability than any other triptan, with more than two thirds of the administered dose…”
Get full text
Journal Article -
9
Non-oral formulations of triptans and their use in acute migraine
Published in Current pain and headache reports (01-06-2005)“…The introduction of triptans (5-HT (1B/1D) agonists) into clinical practice has expanded the therapeutic options for doctors treating migraine sufferers. The…”
Get full text
Journal Article -
10
Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets: Express track
Published in Clinical therapeutics (01-04-2005)“…The gastric stasis that commonly accompanieBackground:722 migraine headache may impair absorption of conventional oral tablets in the stomach. A…”
Get full text
Journal Article -
11
-
12
The burden of migraine to the individual suffer: a review
Published in European journal of neurology (01-11-1998)“…This review of the literature reveals that migraine is a common, chronic condition featuring episodic attacks which vary in severity and sympatomatology…”
Get full text
Journal Article -
13
Sumatriptan Injection and Tablets in Clinical Practice: Results of a Survey of 707 Migraineurs
Published in Headache (01-11-1998)“…This report from the Gothenburg Migraine Clinic in Sweden describes the results of a telephone survey of over 700 patients using open‐label sumatriptan tablets…”
Get full text
Journal Article -
14
Measuring disability and quality of life in migraine
Published in Drugs of today (Barcelona, Spain : 1998) (01-01-2003)“…Although eight out of ten people suffer from different types of headaches, the severity of their pain is often not communicated properly to their doctors…”
Get full text
Journal Article